Advaxis

Results: 9



#Item
1July 22, 2014 Advaxis and MedImmune Partner on Immuno-Oncology Combination Clinical Trial PRINCETON, N.J., July 22, 2014 (GLOBE NEWSWIRE) --Advaxis, Inc.

July 22, 2014 Advaxis and MedImmune Partner on Immuno-Oncology Combination Clinical Trial PRINCETON, N.J., July 22, 2014 (GLOBE NEWSWIRE) --Advaxis, Inc.

Add to Reading List

Source URL: content.stockpr.com

Language: English - Date: 2016-01-08 22:33:57
    2What’s Hot in Pediatric Infectious Diseases? Tobias R. Kollmann MD PhD Division of Infectious & Immunological Diseases Department of Pediatrics University of British Columbia

    What’s Hot in Pediatric Infectious Diseases? Tobias R. Kollmann MD PhD Division of Infectious & Immunological Diseases Department of Pediatrics University of British Columbia

    Add to Reading List

    Source URL: ammi.ca

    Language: English - Date: 2012-07-13 15:53:29
    3PowerPoint Presentation - Listeria monocytogenes as a tumor immunotherapeutic

    PowerPoint Presentation - Listeria monocytogenes as a tumor immunotherapeutic

    Add to Reading List

    Source URL: osp.od.nih.gov

    Language: English - Date: 2013-12-16 11:10:30
    4

    PDF Document

    Add to Reading List

    Source URL: pluristem.com

    Language: English - Date: 2014-03-19 09:50:43
    5

    PDF Document

    Add to Reading List

    Source URL: www.pluristem.com

    Language: English - Date: 2014-03-19 09:50:43
    6What’s Hot in Pediatric Infectious Diseases? Tobias R. Kollmann MD PhD Division of Infectious & Immunological Diseases Department of Pediatrics University of British Columbia

    What’s Hot in Pediatric Infectious Diseases? Tobias R. Kollmann MD PhD Division of Infectious & Immunological Diseases Department of Pediatrics University of British Columbia

    Add to Reading List

    Source URL: www.ammi.ca

    Language: English - Date: 2012-07-13 15:53:29
    7Empowering the immune system from within™ Corporate Presentation July 2014 Forward Looking Statements This presentation contains forward-looking statements, including, but not limited to:

    Empowering the immune system from within™ Corporate Presentation July 2014 Forward Looking Statements This presentation contains forward-looking statements, including, but not limited to:

    Add to Reading List

    Source URL: content.stockpr.com

    Language: English - Date: 2014-07-11 09:16:34
    8ADVAXIS TO INITIATE CLINICAL DEVELOPMENT OF ADXS-cHER2 IMMUNOTHERAPY TO TREAT PEDIATRIC BONE CANCER Clinical Data in Canine Osteosarcoma Presented at Sarcoma Foundation of America Annual Conference PRINCETON, NJ, May 5,

    ADVAXIS TO INITIATE CLINICAL DEVELOPMENT OF ADXS-cHER2 IMMUNOTHERAPY TO TREAT PEDIATRIC BONE CANCER Clinical Data in Canine Osteosarcoma Presented at Sarcoma Foundation of America Annual Conference PRINCETON, NJ, May 5,

    Add to Reading List

    Source URL: www.curesarcoma.org

    Language: English - Date: 2014-05-07 15:56:33
    9June 2, 2010 Advaxis and Department of Homeland

    June 2, 2010 Advaxis and Department of Homeland

    Add to Reading List

    Source URL: content.stockpr.com

    Language: English - Date: 2013-11-07 13:33:50